Condition

Benign Prostatic Hyperplasia With Outflow Obstruction clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Benign Prostatic Hyperplasia With Outflow Obstruction clinical trials that are recruiting, at sites in 2 countries (most in Egypt (2), Turkey (Türkiye) (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Benign Prostatic Hyperplasia With Outflow Obstruction clinical trials

StudyPhaseWhereStatusRegistered
Tri-lobar HoLEP vs En-bloc HoLEP: learning curves in men with enlarged prostates — Tanta Recruiting Oct 22, 2026
Comparing two surgical methods for treating enlarged prostate — Qina, Qena Governorate Recruiting May 21, 2025
Examining the link between urine proteins and urinary symptoms in men with prostate enlargement — Istanbul Recruiting Feb 20, 2024

All recruiting trials (3)

Related topics

Lower Urinary Tract Obstructive Syndrome

Quick answers

How many Benign Prostatic Hyperplasia With Outflow Obstruction clinical trials are recruiting right now?

3, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Egypt (2 trials), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.